Table 3.
Data at 1-year follow-up., n = 165
| BCVA | 0.32 ± logMAR Snellen decimal BCVA 0.5 or better 72.1% (72.7% in the reposition group and 69.7% in the exchange group) |
| IOP | 18.44 ± 5.96 |
| Topical treatment for reducing IOP | n = 59 (35.8%) |
| Pressure issuea | n = 78 (47.3%) |
| Procedure to lower the IOP at or after surgical correction | n = 18 (10.9%; all cyclophotocoagulation) |
| Reattachment of the IOL after surgery | n = 6 (3.6%) |
| IOL exchange | n = 1 (0.6%) |
| Addressed vitreous problems after surgery | YAG treatment of strands, n = 6 (3.6%) |
| Anterior vitrectomy, n = 1 (0.6%) | |
| Pars plana vitrectomy, n = 1 (0.6%) |
BCVA best corrected visual acuity, logMAR logarithm of the minimal angle of resolution, IOP intraocular pressure IOL intraocular lens
aCases with at least one of the following: ongoing topical treatment for reducing IOP, IOP of at least 23 mmHg and previous glaucoma surgery